Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Derick

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Ophthalmology|August 1, 1993
Late argon laser suture lysis after mitomycin C trabeculectomyK S Pappa, R J Derick, P A Weber, et al.
Ophthalmology|March 21, 1998
Hemorrhagic ocular complications associated with the use of systemic thrombolytic agentsL J Chorich, R J Derick, R B Chambers, et al.
Ophthalmology|March 1, 1992
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover studyR J Derick, A L Robin, J Tielsch, et al.
Ophthalmology|January 1, 1997
Brimonidine tartrate: a one-month dose response studyR J Derick, A L Robin, T R Walters, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Ophthalmology|August 1, 1993
Late argon laser suture lysis after mitomycin C trabeculectomyK S Pappa, R J Derick, P A Weber, et al.
Ophthalmology|March 21, 1998
Hemorrhagic ocular complications associated with the use of systemic thrombolytic agentsL J Chorich, R J Derick, R B Chambers, et al.
Ophthalmology|March 1, 1992
Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover studyR J Derick, A L Robin, J Tielsch, et al.
Ophthalmology|January 1, 1997
Brimonidine tartrate: a one-month dose response studyR J Derick, A L Robin, T R Walters, et al.
Pageof 2